Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Metagenomics in Healthcare Market Size Growth Rate by Type (2014-2025)
1.4.2 Sample Extraction Kits
1.4.3 Metagenomics Kits
1.5 Market by Application
1.5.1 Global Metagenomics in Healthcare Market Share by Application (2019-2025)
1.5.2 Pharmaceutical Industries
1.5.3 Biotechnology Companies
1.5.4 Pathology Laboratories
1.5.5 Academic and Research Laboratories
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Metagenomics in Healthcare Market Size
2.2 Metagenomics in Healthcare Growth Trends by Regions
2.2.1 Metagenomics in Healthcare Market Size by Regions (2019-2025)
2.2.2 Metagenomics in Healthcare Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Metagenomics in Healthcare Market Size by by Players
3.1.1 Global Metagenomics in Healthcare Revenue by by Players (2014-2019)
3.1.2 Global Metagenomics in Healthcare Revenue Market Share by by Players (2014-2019)
3.1.3 Global Metagenomics in Healthcare Market Concentration Ratio (CR5 and HHI)
3.2 Metagenomics in Healthcare Key Players Head office and Area Served
3.3 Key Players Metagenomics in Healthcare Product/Solution/Service
3.4 Date of Enter into Metagenomics in Healthcare Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Metagenomics in Healthcare Market Size by Type (2014-2019)
4.2 Global Metagenomics in Healthcare Market Size by Application (2014-2019)
5 North America
5.1 North America Metagenomics in Healthcare Market Size (2014-2019)
5.2 Metagenomics in Healthcare Key Players in North America
5.3 North America Metagenomics in Healthcare Market Size by Type
5.4 North America Metagenomics in Healthcare Market Size by Application
6 Europe
6.1 Europe Metagenomics in Healthcare Market Size (2014-2019)
6.2 Metagenomics in Healthcare Key Players in Europe
6.3 Europe Metagenomics in Healthcare Market Size by Type
6.4 Europe Metagenomics in Healthcare Market Size by Application
7 China
7.1 China Metagenomics in Healthcare Market Size (2014-2019)
7.2 Metagenomics in Healthcare Key Players in China
7.3 China Metagenomics in Healthcare Market Size by Type
7.4 China Metagenomics in Healthcare Market Size by Application
8 Japan
8.1 Japan Metagenomics in Healthcare Market Size (2014-2019)
8.2 Metagenomics in Healthcare Key Players in Japan
8.3 Japan Metagenomics in Healthcare Market Size by Type
8.4 Japan Metagenomics in Healthcare Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Metagenomics in Healthcare Market Size (2014-2019)
9.2 Metagenomics in Healthcare Key Players in Southeast Asia
9.3 Southeast Asia Metagenomics in Healthcare Market Size by Type
9.4 Southeast Asia Metagenomics in Healthcare Market Size by Application
10 India
10.1 India Metagenomics in Healthcare Market Size (2014-2019)
10.2 Metagenomics in Healthcare Key Players in India
10.3 India Metagenomics in Healthcare Market Size by Type
10.4 India Metagenomics in Healthcare Market Size by Application
11 Central & South America
11.1 Central & South America Metagenomics in Healthcare Market Size (2014-2019)
11.2 Metagenomics in Healthcare Key Players in Central & South America
11.3 Central & South America Metagenomics in Healthcare Market Size by Type
11.4 Central & South America Metagenomics in Healthcare Market Size by Application
12 International Players Profiles
12.1 Illumina
12.1.1 Illumina Company Details
12.1.2 Company Description and Business Overview
12.1.3 Metagenomics in Healthcare Introduction
12.1.4 Illumina Revenue in Metagenomics in Healthcare Business (2014-2019))
12.1.5 Illumina Recent Development
12.2 QIAGEN
12.2.1 QIAGEN Company Details
12.2.2 Company Description and Business Overview
12.2.3 Metagenomics in Healthcare Introduction
12.2.4 QIAGEN Revenue in Metagenomics in Healthcare Business (2014-2019)
12.2.5 QIAGEN Recent Development
12.3 PerkinElmer
12.3.1 PerkinElmer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Metagenomics in Healthcare Introduction
12.3.4 PerkinElmer Revenue in Metagenomics in Healthcare Business (2014-2019)
12.3.5 PerkinElmer Recent Development
12.4 Thermo Fisher Scientific
12.4.1 Thermo Fisher Scientific Company Details
12.4.2 Company Description and Business Overview
12.4.3 Metagenomics in Healthcare Introduction
12.4.4 Thermo Fisher Scientific Revenue in Metagenomics in Healthcare Business (2014-2019)
12.4.5 Thermo Fisher Scientific Recent Development
12.5 Oxford Nanopore Technologies
12.5.1 Oxford Nanopore Technologies Company Details
12.5.2 Company Description and Business Overview
12.5.3 Metagenomics in Healthcare Introduction
12.5.4 Oxford Nanopore Technologies Revenue in Metagenomics in Healthcare Business (2014-2019)
12.5.5 Oxford Nanopore Technologies Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Illumina、QIAGEN、PerkinElmer、Thermo Fisher Scientific、Oxford Nanopore Technologies